Jito Foundation partners with Solana Company to expand infrastructure in APAC

Jito Foundation and Solana Company (NASDAQ: HSDT) announced a strategic partnership to develop institutional blockchain infrastructure across the Asia-Pacific region, according to a press release statement.

The collaboration will focus on deploying high-performance Solana validators through Solana Company's Pacific Backbone network, which operates across Hong Kong, Singapore, Japan, and South Korea. These validators will run the Jito Block Assembly Marketplace, connecting to Jito's block-building infrastructure for transaction processing on the Solana network.

The partnership includes developing staking and yield solutions around JitoSOL for institutional investors, including asset managers and regulated financial entities. Solana Company will deliver these offerings through its advisory service model to meet compliance requirements for large-scale capital allocators.

The organizations plan to implement a joint go-to-market strategy for institutional adoption in the APAC region, including research, educational initiatives, and industry engagements focused on staking and validator operations.

"APAC is one of the most important regions for institutional crypto adoption, and this partnership reflects our commitment to building the infrastructure and relationships we believe are needed to support that growth," said Marc Liew, Head of APAC at the Jito Foundation.

Teddy Hung, Head of Business Development and Advisory at Solana Company, stated that "institutional blockchain adoption is no longer a question of if, but of what and how."

Solana Company describes itself as a digital asset treasury focused on acquiring Solana tokens, created in partnership with Pantera and Summer Capital. The Jito Foundation coordinates ecosystem activities for Solana's Market Layer and the Jito Network.

You May Also Be Interested In

• OpenAI launches cybersecurity tools and open-source patching program
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• RedHill Biopharma closes $6M private placement with warrant upside